Celgene Corp (CELG)

CELG (:Drugs) EQUITY
$103.41
pos +0.00
+0.00%
Today's Range: 102.39 - 108.34 | CELG Avg Daily Volume: 5,668,900
Last Update: 04/29/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $108.03
52 Week Range: $92.98 - $140.72
Oustanding Shares: 781,664,535
Market Cap: 84,443,219,716
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 12 12 13
Moderate Buy 1 1 1 1
Hold 3 3 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.44 1.44 1.31
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
0.00 55.60 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 20.70 0.70 0.19
Net Income -19.90 0.10 0.03
EPS -18.80 0.20 0.06
Earnings for CELG:
EBITDA 2.96B
Revenue 9.26B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.23 $1.27 $5.06 $5.01
Number of Analysts 2 2 1 1
High Estimate $1.26 $1.29 $5.06 $5.11
Low Estimate $1.19 $1.25 $5.06 $4.91
Prior Year $1.08 $1.12 $4.08 $5.06
Growth Rate (Year over Year) 13.43% 13.39% 24.02% -0.99%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Improving momentum suggests we could have an intermediate-term rally, possibly taking CELG above $120.

Some Stocks Are Really Cheap Real Money Pro($)

There are lots of winners in the first quarter.

My Takeaways and Observations Real Money Pro($)

The U.S. dollar strengthened modestly. I discussed our currency this morning.  The price of crude oil dropped by 77 cents and closed at $43.40 Natural gas was flat. Gold was quiet, losing $3.60 to $1,250. Agricultural commodities trade as though they are HFT (high-frequency trading) influenced! -- wheat -11.00, corn -11.50, soybean +9.25 and oats -5.50. Lumber was flat. Bonds were lower, with iShares 20+ Year Treasury Bond ETF (TLT) down 65 cents. The 10-year U.S. note rose by two basis points to 1.86% and the 30-year by three basis points to 2.69%. Municipals were flat. Closed-end municipal bond funds were mixed. High yield was down. Blackstone/GSO Strategic Credit Fund (BGB) rose nicely, by eight cents to $13.72. Though down on the day, banks held up well considering the recent strength; however, JPMorgan Chase (JPM) was down by 74 cents. I should have stayed with yesterday's Financial Select Sector SPDR ETF (XLF) short. I will revisit as I expect a correction of plus or minus 5% in these names post haste. Brokerages gave back recent gains. Morgan Stanley (MS) was down 15 cents and Goldman Sachs (GS) down $2.00 Retail was lower, with Wal-Mart (WMT), Home Depot (HD) and Lowe's (LOW) all down, but by less than a beaner each. Under Armour (UA) was an upside standout. Old tech, except IBM (IBM), which was up $2.62, was lower, led by Microsoft following its earnings report. I will dissect Mr. Softee tonight and I am awaiting the conference call in a few minutes. My feedback will be discussed tomorrow. Ag equipment was lower, with Caterpillar (CAT) down 72 cents and Deere (DE) down $1.71. Staples continued their schmeissing -- is the safety trade is over? Good sale earlier in the week in former long Procter & Gamble (PG), which was down 74 cents; it is down almost $3 since my exit two days ago. Best Ideas short Coca-Cola (KO) continues to give gas and Kimberly-Clark (KMB) got whacked by $3.50. Media was lower, but Comcast (CMCSA) and Disney (DIS) only by a half a buck or so each. Biotech was a standout; iShares Nasdaq Biotechnology ETF (IBB) rose by a bit over 2%, led by Celgene (CELG) and Gilead Sciences (GILD). Former spec holding Intrexon (XON) was down $10 after a negative Seeking Alpha report. I expect more big losses ahead in secondary and tertiary biotech names. (T)FANG got declawed, led by Alphabet and its after-hours miss. NOSH was ouch, led by the SBUX miss. CRABBY was also in a rotten mood. In individual names, fav DuPont (DD) was a standout on the upside, rising 60 cents. Potash (POT) was up a dime, and Twitter (TWTR) was unchanged. Here are some great contributions on today's RealMoneyPro site: Jim "El Capitan" Cramer sings Bob Dylan (The Times They are a Changin').  Tim "Not Phil or Judy" Collins on how to play MSFT and GOOGL.  Dick Arms on the market -- always a good read.  Robert "Not Rita" Moreno likes McDonald's (MCD) on the short side; I like this contrary technical take. (The stock is loved by everyone!)  Interesting observation from Brian Sozzi on the message on emerging growth markets delivered by PepsiCo (PEP) and Coca-Cola. 
This will still be fourth quarter in a row that profits have declined year over year.

My Takeaways and Observations Real Money Pro($)

Another day in which what was bad -- cyclicals, energy and banking -- is good again. The U.S. dollar strengthened -- that, too, is not supposed to be good for equities. Crude oil reversed from 2016 highs established earlier in the day. closing down by 38 cents to $41.79. Natural gas climbed by three cents. Gold was down $12.60 to $1,249. Monster move higher in agricultural commodities: wheat +0.25, corn +11.00. soybean +20.5 -- to the moon, Alice.   Bonds climbed, with iShares 20-Year+ Treasury Bond ETF (TLT) up 50 cents. The 10-year and the 30-year barely moved. Yields unchanged. Municipals were slightly higher. High yield prospered, with iShares iBoxx High Yield Corporate Bond ETF (HYG) up 60 cents and SPDR Barclays High Yield Bond ETF (JNK) up 25 cents. Blackstone/GSO Strategic Credit Fund (BGB) was up a nickel to a new recent high of $13.90. Banks were the world's fair on a slight JPMorgan Chase (JPM) beat against much-lowered expectations from a few months ago. Citigroup (C) and Bank of America (BAC) are on tap later this week. Notably, Deutsche Bank (DB) dead-catted by 8%. Brokerages ripped higher on better-than-expected capital markets activity within the JPM report. Morgan Stanley (MS) was up more than a beaner and Goldman Sachs (GS) was up $5. Life insurance stocks also strong. Autos rebounded, with General Motors (GM) up $1.05 and Ford (F) up 25 cents as investors are willing to pay more for a dollar of earnings that are peaking. Defensive consumer nondurables were anything but defensive as the market continues to rotate to more aggressive names. Staples were hit, including Best Ideas List long Procter & Gamble (PG).  Old tech was higher, but less than the market. IBM (IBM) continues its skein after an upgrade a few days ago. Modest gains for Intel (INTC), Cisco (CSCO) and Microsoft (MSFT). iShares Nasdaq Biotechnology ETF (IBB) was up 1.9% despite the Theranos news and the credit release at Valeant Pharmaceuticals (VRX). Allergan (AGN) was lower. My former biotech basket of speculative stocks was mixed. Celgene (CELG), Acadia Pharmaceuticals (ACAD), Intrexon (XON), Portola Pharmaceuticals (PTLA) and Sage Therapeutics (SAGE) were strong. Media joined the fun. Comcast (CMCSA) was up only 20 cents but Disney (DIS) was up two beaners. Retail was higher, but not materially so after the weak data. (T)FANG with the exception of a weak Facebook (FB) was higher on the day. But there was distinct underperformance against the averages. NOSH was mixed and also underperformed. CRABBY was led by C. In individual stocks, Apple (AAPL) was up $1.60 and Twitter (TWTR) rose almost 5%, while Potash (POT) and Radian Group (RDN) also moved higher. Limited trading today. Here is some great stuff on RealMoneyPro today: El Capitan on CSX  (CSX) and Jeremy LaKosh on the same subject.  RevShark's always-informative market takes.  Carleton English on the bears' dilemma.  Mike Norman's I told you so.  Ed Ponsi "Scheme" does the
Stocks like Facebook or Palo Alto Networks are expensive for the moment.

My Takeaways and Observations Real Money Pro($)

The U.S. dollar was essentially flat today. Crude oil rose by 54 cents to $40.26. It's amusing how the $20 crude forecasts have disappeared, and so has the self-confidence that was expressed back then! Nat gas down by seven cents. Gold ripped by another $13.70, to $1,257. Agricultural prices got schmeissed (see my POT comments in my Diary): wheat -13.75 and corn -5.5, but soybeans +10.75. Lumber was flat. Bonds were down, flat and now back down. iShares 20+ Year Treasury Bond (TLT) down 25 cents. The yields on the 10-year (1.72%) and 30-year (2.56%) were flat. Municipals were unchanged, though closed-end municipal bond funds continue to soar, relatively speaking. And I am getting very upset for selling out a few months ago, because it was a theme consistent with my slower growth thesis. I suppose "lower for longer" is now becoming consensus and is fueling the space. High yield was well-bid. But BGB had an outsize move of 16 cents following my mention in Barron's.  Banks prospered, but I think it's likely just noise. Brokerages prospered -- Morgan Stanley (MS) up 50 cents and Goldman Sachs (GS) up $3.50 -- for the same reason that banks are higher? GS had a large ($5 billion) mortgage settlement announced today. Life insurance stocks surged, led by Lincoln National (LNC) and Prudential (PRU). I added to Hartford Financial Services Group (HIG) today. Berkshire (BRK.B) better; I remain short. Retail stocks were mixed. Check out the Market Vectors Retail ETF (RTH) chart -- it is either breaking out or about to fail and at a critical juncture. I will have more on the sector tomorrow morning. Old tech was mixed, with little substantive price movement. Energy stock rose but by lesser amounts than one would think relative to the price in crude oil.  That said, they rose greater than the commodity on Thursday and Friday. Consumer nondurables were mixed. My fav Procter & Gamble (PG) was down a quarter and Coca-Cola (KO), my short, was down by like amount. Biotech disappointed -- down 1% -- as Allergan (AGN) and Valeant (VRX) were downside leaders. My former biotech basket weakened. While Gilead Sciences (GILD) was 50 cents, Celgene (CELG), Sage Therapeutics (SAGE) and Intrexon (XON) got hit. Autos were better bid, with Ford (F) up 15 cents and General Motors (GM) up 30 cents. Too bad I am short both. Media was mildly higher, with Disney (DIS) up 60 cents and Comcast (CMCSA) up 35 cents. (T)FANG was mixed. Tesla (TSLA) was a feature -- up $9 in the early going, now down on the day on the SUV recall. Amazon (AMZN) and Alphabet (GOOGL) up about $5 each. NOSH was weak -- downside leaders were Nike (NKE) and O'Reilly Automotive (ORLY). CRABBY shined, with all components save Radian Group (RDN) higher . In individual stocks, watch Sears (SLHD) -- the drop is getting worrisome and a failure would have important real estate and employment consequences. Caterpillar (CAT), a short, continues to rally -- up by nearly a beaner. Apple (AAPL) was up $1.20 and close to $110 -- I will be adding to my short on any further strength. I wanted to close Takeaways by acknowledging the loss of an old friend, Jack O'Neill. Today was Jack's funeral.  Many of my friends were at Campbell's Funeral Home to pay tribute to this great and unique man. He owned JG Melon, an iconic hamburger joint in New York City on Third Avenue in the Seventies.  Jack was an occasional golf opponent and partner of mine; he often shot his age -- in the low 80s. He was something of a Damon Runyon character -- the type of personality that no longer exists. He was a pal of Toots Shor and the rest of the fascinating personalities who inhabited the saloon scene in Manhattan decades ago. The loss of Jack is a big loss to his families and friends. He will be sorely missed. They don't make them like Jack anymore. R.I.P
Is the Market Going to Cooperate With Me, Or Do I Cooperate With It?

That Was the Week That Was Real Money Pro($)

Let's review.

Bret Jensen Reporting for Duty Real Money Pro($)

Good morning -- Bret Jensen here! As always, it's good to be standing in for Doug Kass.

Columnist Conversations

Mine and many other reviews of the meeting coming Monday, but the quick highlights to whet your appetite: 1)...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.